B. Riley lowered the firm’s price target on Arrowhead (ARWR) to $38 from $51 and keeps a Buy rating on the shares following the fiscal Q1 report. The firm says Ionis Pharmaceuticals’ (IONS ...

Bartlesville City Council approves Arrowhead LLC to manage Price and Arutunoff Fields, ensuring a smooth transition for youth ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Shares of Arrowhead Pharmaceuticals Inc. ($ARWR) and Sarepta Therapeutics Inc. ($SRPT) climbed on Wednesday despite Wall Street trimming price targets after the ...

Arrowhead's stock has underperformed compared to the SPDR S&P Biotech ETF (XBI) index in recent years. This underperformance has led some analysts to view the current stock price as an attractive ...

Arrowhead Pharmaceuticals stock could remain under pressure in the near-term, but improved financial outlook and pipeline ...

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms ...

The Bartlesville City Council approved an agreement Friday for locally-owned Arrowhead, LLC to manage the Price Fields ...

Rhumbline Advisers raised its stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 2.1% in the fourth ...

Only select options below that are in addition to standard equipment and equipment noted in the manufacturer or year notes show above. If you are uncertain of what came standard, please contact your ...

In a report released today, Luca Issi from RBC Capital maintained a Buy rating on Arrowhead Pharmaceuticals (ARWR – Research Report), with a ...

Here’s how ticket prices look around Arrowhead Stadium on the Ticketmaster website. All ticket availability and prices are accurate as of Thursday, Jan. 9. In the same section just 18 rows down ...